WC
NVO

Wynn Capital’s Novo Nordisk NVO Stock Holding History

Wynn Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
8,605
+960
+13% +$41.2K 0.18% 80
2026
Q1 		$281K Buy
7,645
+600
+9% +$28.4K 0.14% 94
2025
Q4 		$358K Sell
7,045
-321
-4% -$16.4K 0.17% 83
2025
Q3 		$409K Hold
7,366
– – 0.2% 81
2025
Q2 		$508K Buy
7,366
+276
+4% +$18.8K 0.27% 70
2025
Q1 		$492K Buy
7,090
+45
+0.6% +$3.72K 0.29% 67
2024
Q4 		$606K Buy
7,045
+75
+1% +$8.11K 0.38% 58
2024
Q3 		$830K Hold
6,970
– – 0.54% 50
2024
Q2 		$995K Sell
6,970
-200
-3% -$26.5K 0.74% 41
2024
Q1 		$921K Sell
7,170
-75
-1% -$8.93K 0.71% 42
2023
Q4 		$749K Buy
+7,245
New +$716K 0.61% 47

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Wynn Capital's NVO Position: Q2 2026 in Review

Wynn Capital increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $41.2K and bringing the position to 8,605 shares worth $413K. The position accounts for 0.18% of the portfolio, ranked #80.

Wynn Capital first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $995K in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Wynn Capital held 8,605 shares of Novo Nordisk worth $413K as of Q2 2026.
  • Wynn Capital bought 960 Novo Nordisk shares in Q2 2026, an estimated $41.2K.
  • Novo Nordisk made up 0.18% of Wynn Capital's portfolio in Q2 2026, its #80 holding.
  • Wynn Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Wynn Capital's Novo Nordisk position peaked at $995K in Q2 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.